JNJ

Glaxo Joins J&J in $200 Million Fund With Index Ventures
Bloomberg
Wed, 03/21/12 - 10:06 am
GSK
JNJ
venture capital
Johnson & Johnson Joins the Shareholder Revolution
Forbes
Mon, 03/19/12 - 09:20 am
JNJ
shareholders
9 Pharma Buys for a Healthy Portfolio
Investor Place
Sun, 03/18/12 - 11:26 am
Novo Nordisk
Valeant Pharmaceuticals
GSK
Abbott Laboratories
Eli Lilly
JNJ
Pfizer
Merck
Sanofi
6 Pharmaceuticals Paying 3%
Seeking Alpha
Sat, 03/17/12 - 12:10 pm
Abbott Laboratories
Bristol-Myers Squibb
Eli Lilly
JNJ
Merck
Pfizer
Johnson & Johnson Passes This Key Test
Motley Fool
Sat, 03/17/12 - 10:50 am
JNJ
J&J CEO Weldon retirement pay seen at $143.5 mln
Reuters
Thu, 03/15/12 - 09:07 am
JNJ
William Weldon
executive pay
7 Cancer Drug Stocks to Know Right Now
Seeking Alpha
Wed, 03/14/12 - 10:54 am
Seattle Genetics
Celldex
Arqule
Daiichi Sankyo
JNJ
Medivation
Dendreon
Aveo Pharmaceutical
Ariad Pharmaceuticals
AstraZeneca
Array Biopharma
Oncothyreon
A Drug Class Back From the Dead?
Motley Fool
Wed, 03/14/12 - 09:42 am
Pfizer
Regeneron
JNJ
Sanofi
AstraZeneca
FDA
NGF blockers
Don't Expect Too Much From New Pain Drugs, Analyst Says
Forbes
Tue, 03/13/12 - 11:07 am
painkillers
NGF blockers
Amgen
Regeneron
JNJ
Vical's Allovectin: Why Hasn't The Trial Been Stopped?
Seeking Alpha
Mon, 03/12/12 - 08:44 pm
Vical
Allovectin
metastatic melanoma
melanoma
Zytiga
JNJ
FDA panel recommends lifting research hold on nerve-blocking pain drugs, despite safety risk
Yahoo/AP
Mon, 03/12/12 - 05:47 pm
FDA
painkillers
Pfizer
JNJ
Regeneron
arthritis
J&J Said to Face Demand to Raise Risperdal Accord Offer by $800 Million
Bloomberg
Mon, 03/12/12 - 05:45 pm
JNJ
Risperdal
Johnson & Johnson: A Solid Buy Candidate For 2012
Seeking Alpha
Mon, 03/12/12 - 05:30 pm
JNJ
Dendreon Faces New Competition As J&J Impresses With Prostate Cancer Drug
Seeking Alpha
Sun, 03/11/12 - 12:12 pm
Zytiga
Provenge
prostate cancer
JNJ
Dendreon
U.S. nixes tentative $1 bln settlement with J&J -WSJ
Reuters
Sat, 03/10/12 - 04:08 pm
JNJ
legal
Risperdal
J&J Prostate Cancer Drug Scores Big Win, Hurts Dendreon, Helps Medivation
TheStreet.com
Thu, 03/8/12 - 10:15 am
JNJ
prostate cancer
Dendreon
Provenge
Medivation
Zytiga
MDV3100
U.S. Regulators Probes Resuming Painkiller Trials Tied to Joint Failure
Bloomberg
Thu, 03/8/12 - 09:55 am
Pfizer
JNJ
FDA
joint failure
painkillers
fulranumab
Sanofi
Regeneron
tanezumab
REGN475/SAR164877
US warns Synthes on violations; threatens fine
Reuters
Tue, 03/6/12 - 11:23 am
Synthes
JNJ
warnings
Most Popular Drug Manufacturers among Hedge Funds
Motley Fool
Mon, 03/5/12 - 06:15 pm
Pfizer
hedge funds
Sanofi
JNJ
Merck
Abbott Laboratories
Eli Lilly
Bristol-Myers Squibb
Johnson & Johnson Could Double In 5 Years
Seeking Alpha
Sun, 03/4/12 - 12:19 pm
JNJ

Pages